counterregul
afford
special
regulatori
cell
popul
immunosuppress
cytokin
critic
balanc
immun
outcom
inhibitori
potenti
establish
suppress
cytokin
tgfb
well
elucid
divers
inflammatori
scenario
conjunct
key
role
treg
develop
function
despit
earli
predict
immunomodulatori
role
heterodim
placent
trophoblast
biolog
remain
elus
establish
tregrestrict
inhibitori
cytokin
sinc
tregderiv
shown
exhibit
suppress
activ
rang
autoimmun
diseas
cancer
model
recent
studi
begin
explor
cellular
sourc
breg
treg
despit
new
cellular
sourc
target
mode
suppress
remain
restrict
inhibit
prolifer
induct
induc
regulatori
cell
popul
refer
review
explor
earli
begin
statu
quo
futur
prospect
biolog
unparallel
opportun
target
multipl
immunosuppress
popul
treg
breg
treg
highli
excit
offer
tremend
promis
translat
standpoint
particularli
cancer
immunotherapi
cytokin
immun
regul
establish
suppress
cytokin
tgfb
newcom
critic
constitu
regulatori
neg
feedback
loop
tolerancepromot
pathway
integr
immun
mmune
protect
orchestr
balanc
interplay
event
without
trigger
aberr
respons
self
foreign
antigen
underli
autoimmun
allergi
chronic
infect
cancer
vari
respons
shape
larg
intercellular
commun
mediat
messeng
molecul
call
cytokin
cytokin
small
solubl
protein
secret
immun
cell
respons
divers
extern
stimuli
lymphocyt
activ
receptor
engag
signal
appropri
costimul
signal
initi
immun
respons
drive
clonal
expans
antigenspecif
cell
cytokin
signal
signal
critic
function
matur
respons
appropri
effector
lineag
helper
cytotox
memori
antibodysecret
potenti
cytokin
member
sever
distinct
famili
base
structur
receptor
composit
hematopoietin
interleukin
interferon
tnf
famili
immunoglobulin
supergen
famili
chemokin
adipokin
function
autocrin
paracrin
manner
coordin
plethora
biolog
event
rang
embryon
develop
cellular
differenti
migrat
diseas
pathogenesi
even
cognit
function
age
cytokin
biolog
extrem
complex
owe
pleiotrop
natur
function
redund
also
grow
addit
new
member
exist
famili
cytokin
receptor
dinarello
yoshimoto
yoshimoto
cytokin
famili
encompass
proinflammatori
suppress
member
often
net
effect
cytokin
milieu
determin
immun
outcom
trigger
immun
system
elicit
releas
proinflammatori
cytokin
chemokin
innat
immun
cell
initi
innat
respons
hold
enemi
bay
adapt
immun
kick
special
armor
effector
cell
exhibit
distinct
cytokin
profil
function
cytokinedriven
cellular
influx
expans
promot
inflamm
ultim
lead
clearanc
infect
cytokin
storm
typic
subsid
infect
elimin
autoimmun
respons
curtail
neg
feedback
circuit
provid
suppress
cytokin
banchereau
other
special
regulatori
cell
treg
sakaguchi
other
josefowicz
other
suppress
cytokin
help
restor
immun
equilibrium
homeostasi
minim
collater
damag
host
banchereau
other
better
understand
immun
network
establish
posit
neg
regul
allow
effect
cytokin
modul
therapeut
intervent
system
cytokin
differ
express
pattern
cellular
sourc
signal
circuit
target
suppress
yoshimoto
yoshimoto
typic
act
concert
maxim
suppress
potenti
although
differ
member
may
less
activ
homeostat
divers
inflammatori
scenario
tgfb
highli
express
tissu
basal
condit
li
other
tgfb
signal
indispens
limit
tcell
reactiv
self
mainten
steadyst
immun
homeostasi
toler
thu
mice
germ
line
tgfb
delet
tcellspecif
defici
tgfb
receptor
develop
spontan
multifoc
inflammatori
diseas
associ
exuber
tcell
activ
cytokin
releas
shull
other
li
flavel
tran
true
patient
sezari
syndrom
whose
cell
reduc
express
tgfb
receptor
consequ
unrestrain
tcell
prolifer
capocasal
other
contrast
tgfb
minim
express
unstimul
cell
often
requir
commensalor
pathogendriven
upregul
banchereau
other
although
origin
identifi
cytokin
clear
mani
immun
cell
type
produc
moor
other
sabat
other
saraiva
ogarra
whether
activ
innat
adapt
pathway
play
major
regulatori
role
dampen
inflammatori
respons
inde
mice
lack
highli
suscept
acut
inflamm
exhibit
profound
immun
polar
succumb
coliti
similar
earli
onset
ibd
observ
human
harbor
mutat
gene
encod
receptor
compon
other
togeth
establish
suppress
cytokin
duo
play
domin
role
maintain
steadyst
immun
equilibrium
tame
exuber
respons
environment
interfac
tgfb
play
crucial
role
induct
thymic
develop
treg
xu
other
mahmud
other
tgfb
also
harbor
anoth
uniqu
trait
aid
immunomodulatori
properti
cytokin
transmit
suppress
potenti
effector
cell
caus
gain
regulatori
phenotyp
well
target
dendrit
cell
promot
convers
effector
cell
potent
suppressor
propag
tolerancepromot
state
cell
refer
infecti
toler
gershon
kondo
qin
other
gravano
vignali
tgfb
drive
tcell
convers
itreg
cell
respect
cell
identifi
abil
secret
larg
amount
mild
moder
level
tgfb
other
itreg
induc
peripheri
mani
differ
mechan
contribut
immun
mucos
interfac
chen
other
sun
other
yadav
other
recent
discov
cytokin
endow
suppress
activ
belong
famili
cytokin
unlik
tgfb
similar
minim
express
human
tissu
mainli
induc
inflammatori
condit
li
other
well
support
lack
lethal
defect
mice
genet
delet
compon
unlik
mice
defici
thu
tgfb
function
housekeep
antiinflammatori
cytokin
along
categor
induc
suppress
member
li
other
cytokin
famili
belong
superfamili
type
cytokin
unlik
famili
member
secret
singlesubunit
monom
famili
character
heterodimer
member
form
chain
share
interact
alpha
chain
classic
bundl
cytokin
beta
chain
resembl
solubl
version
cytokin
receptor
jone
vignali
vignali
kuchroo
give
rise
current
member
fig
predominantli
proinflammatori
primarili
suppress
cytokin
vignali
kuchroo
addit
exist
monom
homodim
report
function
natur
antagonist
bioactiv
cytokin
signal
jone
vignali
yoshimoto
yoshimoto
cytokin
signal
uniqu
pair
receptor
chain
fig
signal
util
cell
signal
although
also
signal
homodim
collison
other
signal
transduct
receptor
chain
mediat
jakstat
pathway
key
janu
kinas
mediat
stat
phosphoryl
famili
member
either
stat
util
vari
fig
famili
cytokin
receptor
four
current
member
cytokin
famili
downstream
signal
pathway
signal
signal
signal
util
heterodim
homodim
respect
sawant
hamilton
vignali
receptor
chain
signal
primarili
signal
homodim
mediat
respect
collison
other
homodimer
receptor
enabl
suppress
tcell
prolifer
induc
convers
fig
contrast
tcell
suppress
induct
mediat
heterodimer
receptor
drive
format
heterodim
turn
bind
uniqu
site
promot
collison
other
discuss
detail
recent
studi
also
suggest
signal
b
cell
mediat
heterodim
induc
shen
other
despit
obviou
structur
similar
cytokin
subunit
receptor
compon
downstream
signal
famili
member
display
surprisingli
divers
balanc
function
outcom
secret
activ
antigenpres
cell
b
cell
monocytemacrophag
dendrit
cell
respons
bacteria
bacteri
product
intracellular
parasit
trinchieri
oshea
paul
hunter
stimul
ifng
product
nk
cell
therebi
bridg
innat
adapt
immun
arm
concurr
downregul
thu
inhibit
propag
also
enhanc
cytolyt
activ
macrophag
cell
nk
cell
similar
also
drive
prolifer
oppmann
other
howev
mainli
link
inflammatori
process
associ
differenti
aggarw
other
potent
enhanc
stabil
differenti
lineag
promot
memori
tcell
prolifer
also
aid
dc
cytokin
product
antigen
present
zeng
other
thu
repres
strictli
proinflammatori
member
famili
key
role
develop
first
discov
suggest
proinflammatori
famili
member
due
role
support
develop
ifng
product
inhibit
differenti
program
pflanz
other
villarino
other
howev
recent
studi
reveal
broader
immunomodulatori
role
cytokin
demonstr
inhibit
differenti
target
transcript
factor
rorgt
rora
rorc
well
inhibit
product
diveu
other
also
promot
gener
cell
induct
transcript
factor
cmaf
cytokin
costimulatori
receptor
ico
thu
extend
abil
dampen
inflammatori
process
awasthi
other
fitzgerald
other
stumhof
other
batten
other
pot
other
accumul
studi
support
role
modul
immun
respons
newest
famili
member
focu
review
uniqu
express
pattern
function
unlik
member
predominantli
secret
regulatori
cell
shown
suppress
tcell
prolifer
function
number
vitro
vivo
diseas
model
appear
requir
maxim
suppressor
function
mous
human
treg
other
pillai
other
recent
report
also
produc
regulatori
b
cell
shen
other
wang
other
like
tgfb
also
induc
convers
cell
regulatori
popul
refer
cell
collison
other
cell
function
independ
tgfb
demonstr
exhibit
tolerancepromot
abil
mous
model
parasit
infect
tumor
sinc
discoveri
shown
contribut
regulatori
milieu
wide
varieti
diseas
state
sever
group
therebi
warrant
detail
character
cellular
sourc
target
suppress
mechan
action
interestingli
thu
far
seem
suppress
function
suggest
rel
restrict
pattern
activ
earli
begin
biolog
addit
treg
arsen
archetyp
member
famili
identifi
purifi
cell
cultur
media
epsteinbarr
viru
ebv
transform
b
cell
line
devergn
other
macrophag
ebvtransform
b
cell
could
produc
kda
heterodim
typic
excess
express
ubiquit
seem
restrict
induc
dissoci
gene
regul
hint
possibl
either
subunit
might
addit
partner
thu
discoveri
beta
chain
ebvinfect
b
cell
initi
experi
determin
altern
bind
partner
devergn
other
niedobitek
other
led
first
demonstr
heterodimer
form
novel
potenti
natur
occur
hematopoietin
devergn
other
express
ebvtransform
b
lymphocyt
tonsil
spleen
placent
trophoblast
heterodim
also
coimmunoprecipit
trophoblast
human
fullterm
placenta
devergn
other
propos
heterodim
might
import
immun
modul
howev
function
physiolog
relev
unknown
despit
earli
observ
name
function
given
heterodim
shown
vignali
laboratori
produc
regulatori
cell
requir
maxim
suppress
function
collison
other
rather
came
surpris
field
sinc
subunit
constitu
famili
cytokin
thought
exclus
produc
apc
collison
vignali
also
note
candid
gene
upregul
treg
cellspecif
gene
array
propos
potenti
target
knoechel
other
collison
other
hill
other
zheng
other
appear
constitut
secret
mous
treg
effector
cell
express
boost
follow
cocultur
treg
effector
cell
other
importantli
treg
cell
defici
either
subunit
stimul
alon
follow
cocultur
effector
cell
display
reduc
suppress
function
vitro
fail
control
homeostat
prolifer
coliti
vivo
collison
other
furthermor
recombin
abl
suppress
tcell
prolifer
ectop
express
confer
suppress
potenti
cell
collison
other
studi
first
delin
defin
function
longknown
heterodim
tregrestrict
suppress
cytokin
need
maxim
function
join
rank
tgfb
solubl
cell
contactindepend
mediat
suppress
around
time
anoth
group
gener
fc
fusion
protein
also
demonstr
heterodim
suppress
tcell
prolifer
ifng
product
niedbala
other
also
inhibit
cell
differenti
note
allevi
develop
collageninduc
arthriti
mous
model
inflamm
interestingli
group
report
fc
fusion
protein
could
expand
treg
cell
without
induct
addit
express
retain
suppress
function
niedbala
other
taken
togeth
initi
studi
valid
immunomodulatori
potenti
pave
begin
excit
seri
futur
studi
assess
physiolog
pathophysiolog
role
health
diseas
addit
treg
cell
arsen
spark
tremend
enthusiasm
treg
field
continu
interest
identifi
novel
mechan
treg
suppress
optim
channel
either
boost
inhibit
treg
activ
treg
suppress
inhibitori
receptor
express
cytolysi
granzym
perforin
metabol
disrupt
depriv
adenosin
document
releas
suppress
cytokin
prevail
major
cell
contactindepend
mechan
suppress
inclus
import
categori
treg
suppress
mechan
particularli
fascin
known
inhibitori
mediat
appear
exclus
secret
treg
cell
alon
unlik
tgfb
also
secret
immun
cell
addit
treg
although
view
begun
chang
recent
identif
new
cellular
sourc
critic
differ
brought
forefront
categori
trigger
seri
investig
mechan
suppress
thu
far
shown
exhibit
suppress
activ
mechan
collison
other
gravano
vignali
vignali
kuchroo
regard
suppress
activ
support
experi
demonstr
failur
treg
suppress
tcell
prolifer
vitro
wide
varieti
inflammatori
scenario
vivo
collison
other
wirtz
other
bettini
other
also
valid
gainoffunct
approach
use
recombin
cell
cultur
system
ectop
express
singlechain
fc
fusion
protein
set
decreas
tcell
prolifer
appear
induc
cell
cycl
arrest
mediat
remain
unknown
confirm
nod
transgen
mice
isletspecif
express
bettini
other
mice
exhibit
substanti
reduc
diabet
incid
inflammatori
patholog
owe
reduct
isletresid
cell
even
though
proport
isletinfiltr
cell
phase
compar
beta
cellsecret
block
progress
transit
addit
suppress
prolifer
also
shown
suppress
differenti
effector
cell
lineag
fc
fusion
protein
shown
suppress
differenti
attenu
collageninduc
arthriti
sawant
hamilton
vignali
niedbala
other
anoth
propos
mode
action
treg
expans
exposur
fc
fusion
protein
shown
induc
prolifer
popul
cell
niedbala
other
treg
express
abl
suppress
effector
tcell
prolifer
potenti
contribut
inhibitori
effect
mous
model
arthriti
similarli
anoth
report
treatment
expand
cell
depend
mediat
autoimmun
protect
follow
adopt
transfer
collageninduc
arthriti
model
kochetkova
other
howev
remain
determin
mediat
expans
treg
physiolog
set
last
similar
tgfb
seem
mediat
infecti
toler
belkaid
chen
gravano
vignali
thu
cell
stimul
presenc
suppress
also
convert
regulatori
popul
term
cell
promot
infecti
toler
also
deriv
studi
vignali
group
demonstr
treg
cellmedi
suppress
induc
concert
action
distinct
regulatori
popul
character
secret
term
cell
collison
other
notabl
cell
phenotyp
function
distinct
known
induc
regulatori
popul
tgfbinduc
treg
itreg
treg
express
suppress
exclus
independ
tgfb
known
treg
suppress
mediat
transcript
profil
suggest
cell
exhibit
highli
restrict
gene
signatur
tgfb
indic
limit
rather
global
chang
follow
treatment
cell
mous
cell
exhibit
potent
suppress
potenti
distinct
diseas
model
importantli
inflammatori
milieu
gener
follow
parasit
infect
muri
tumor
inocul
induc
cell
seem
provid
substanti
physiolog
contribut
regulatori
milieu
establish
ntreg
melanoma
model
even
human
cell
could
induc
develop
cell
presenc
collison
other
viralexpos
dc
seyerl
other
human
cell
also
suppress
primari
human
tcell
prolifer
one
excit
featur
induc
regulatori
popul
demonstr
stabil
effici
rel
tgfbitr
cell
cell
almost
effici
ntreg
restor
homeostasi
prevent
autoimmun
mice
limit
tcell
prolifer
lymphopen
set
curtail
inflamm
experiment
autoimmun
enceph
eae
coliti
model
promot
tumor
growth
melanoma
model
cell
also
display
increas
stabil
retain
suppressor
potenti
rel
tgfbinduc
counterpart
follow
recoveri
week
posttransf
immunecompet
host
intrigu
aspect
regulatori
popul
make
cell
safe
attract
therapeut
candid
consid
complex
associ
gener
short
life
span
stabil
ex
vivogener
tgfbitr
cell
collison
other
howev
studi
warrant
fulli
elucid
contribut
cell
divers
diseas
scenario
avail
purifi
remain
major
limit
thu
inhibit
effector
tcell
prolifer
cell
cycl
arrest
modul
tcell
differenti
program
expans
regulatori
cell
induct
cell
emerg
key
mechan
regulatori
function
new
cellular
target
sourc
deciph
inform
like
emerg
expand
scope
influenc
immun
regul
analog
regulatori
cell
treg
counterpart
exist
regulatori
b
cell
breg
role
control
autoimmun
diseas
eae
cia
describ
sever
group
fillatreau
other
mauri
ehrenstein
yanaba
other
barr
other
mauri
bosma
key
focu
breg
cell
field
identifi
phenotyp
marker
better
character
subset
identifi
thu
far
hi
hi
cell
yanaba
other
hi
hi
hi
transit
type
margin
zone
precursor
evan
other
b
cell
ding
other
plasma
cell
neve
other
despit
lack
unifi
signatur
account
regulatori
function
ascrib
regulatori
b
cell
subset
fillatreau
other
banchereau
other
kalampoki
other
fact
breg
cell
also
identifi
human
numer
andor
function
perturb
breg
cell
subset
report
human
autoimmun
diseas
multipl
sclerosi
type
diabet
blair
other
mauri
nistala
howev
b
cell
also
shown
mediat
regulatori
effect
independ
secret
wilson
other
su
other
b
cell
also
induc
treg
manner
floresborja
other
therefor
hard
conceiv
similar
treg
breg
may
also
harbor
rang
suppress
mediat
account
broader
involv
immun
regul
two
recent
studi
focus
elucid
regulatori
mediat
potenti
induc
breg
drive
b
cell
secret
act
independ
synergist
elicit
maxim
breg
function
vivo
shen
other
wang
other
interestingli
beta
chain
treg
inhibitori
cytokin
emerg
one
differenti
regul
gene
transcriptom
analysi
b
cell
costimul
rel
prime
alon
shen
other
analysi
b
cellspecif
express
famili
constitu
show
b
cell
also
constitut
express
alpha
chain
express
thu
bcr
engag
along
stimul
result
increas
transcript
secret
identifi
b
cell
novel
sourc
test
vivo
function
relev
bcellderiv
bone
marrow
chimer
mice
gener
b
cell
lack
either
chain
bcellrestrict
mice
develop
exacerb
eae
protect
typhimurium
salmonella
induc
sepsi
rel
control
shen
other
respons
larg
account
enhanc
antigenpres
potenti
b
cell
associ
higher
express
mhcii
therebi
stimul
higher
prolifer
inflammatori
cytokin
product
cognat
cell
thu
suppress
effect
bcellderiv
mainli
stem
abil
regul
apc
function
b
cell
restrain
inflammatori
cell
infiltr
cell
macrophag
thu
limit
autoimmun
mediat
enhanc
pathogen
clearanc
regulatori
potenti
bcellderiv
confirm
complement
anoth
independ
studi
show
recombin
treatment
induc
breg
breg
effici
suppress
prolifer
b
cell
wang
other
furthermor
also
mediat
convers
b
cell
breg
cell
popul
secret
breg
administr
recombin
breg
cell
effici
control
initi
establish
stage
experiment
autoimmun
uveiti
eau
bregmedi
protect
depend
increas
induct
expans
endogen
breg
treg
inhibit
pathogen
effector
cell
wang
other
thu
studi
provid
support
exist
compar
regulatori
modul
within
b
cell
lineag
serv
common
link
assess
relationship
b
cell
transcript
quantifi
b
cell
hi
plasma
cell
analysi
reveal
hi
plasma
cell
major
sourc
vivo
although
plasma
cell
cotranscrib
togeth
suggest
distinct
regulatori
plasma
cell
subset
secret
shen
other
studi
demonstr
enrich
within
b
cell
shen
other
wang
other
one
major
differ
studi
rel
import
regulatori
function
b
cell
peak
breg
expans
almost
hi
plasma
cell
secret
respect
despit
differ
delet
either
result
similar
exacerb
eae
sever
anim
capabl
produc
either
cytokin
similar
diseas
score
wildtyp
anim
indic
cytokin
function
independ
shen
other
complet
contrast
b
cell
defici
cultur
presenc
test
capac
control
autoimmun
uveiti
eau
loss
complet
abrog
suppress
effect
suggest
final
mediat
suppress
breg
wang
other
compat
vitro
studi
demonstr
addit
neutral
antibodi
abrog
suppress
effect
find
treatment
human
b
cell
also
induc
express
inhibit
bcell
prolifer
suggest
may
hold
promis
autolog
breg
induct
near
futur
conjunct
current
use
largescal
cell
expans
ex
vivo
tedder
leonard
consid
share
subunit
fact
chain
share
famili
also
extend
receptor
chain
downstream
signal
like
receptor
stat
util
would
involv
compon
andor
signal
cascad
howev
sinc
biolog
activ
contrast
sibl
util
complet
novel
signal
transduct
mechan
also
possibl
use
cell
defici
famili
receptor
chain
demonstr
signal
cell
collison
other
interestingli
cell
defici
receptor
chain
complet
resist
suppress
effect
activ
cell
partial
resist
cellmedi
suppress
thu
unlik
capabl
signal
singl
receptor
chain
garber
other
vignali
kuchroo
howev
capac
upregul
express
convers
requir
heterodimer
receptor
demonstr
signal
receptor
combin
cell
homodim
homodim
suffici
mediat
suppress
heterodim
essenti
convers
requir
maxim
suppress
uniqu
heterodim
identifi
major
downstream
mediat
signal
bound
mani
site
promot
initi
transcript
intrigu
heterodim
predomin
stimul
simultan
stimul
ifng
activ
respect
contrast
induc
proinflammatori
respons
recent
breg
studi
propos
new
composit
function
receptor
b
cell
wang
other
unlik
cell
counterpart
silenc
sirnamedi
knockdown
use
neutral
antibodi
affect
inhibit
bcell
prolifer
induct
contrast
silenc
complet
abrog
inhibitori
effect
b
cell
analysi
reveal
signal
receptor
compris
activ
b
cell
wang
other
find
indic
may
mediat
distinct
biolog
activ
divers
cell
type
differenti
receptor
stat
util
fig
composit
receptor
shed
light
potenti
cellular
target
although
ubiquit
express
fairli
restrict
name
activ
cell
nk
cell
b
cell
dendrit
cell
preski
other
grohmann
other
undetect
rest
cell
get
rapidli
induc
presenc
cytokin
ifng
tnfa
collison
other
inde
pretreat
activ
cell
increas
sensit
suppress
collison
other
thu
possibl
upregul
may
prime
cell
suppress
effect
may
underli
perceiv
inhibitori
role
vignali
kuchroo
express
compon
receptor
b
cell
also
primarili
restrict
immun
cell
b
nk
mast
cell
monocyt
neutrophil
pflanz
other
sinc
ubiquit
broad
express
pattern
homodim
may
facilit
suppress
broad
array
cell
type
thu
abil
signal
multipl
receptor
combin
expand
sphere
influenc
also
vari
suppress
impact
consequ
differ
cell
type
regulatori
potenti
highlight
multipl
diseas
model
earlier
studi
mainli
perform
use
mous
strain
defici
collison
vignali
howev
mice
lack
defici
thu
observ
made
could
attribut
effect
either
cytokin
evid
differ
suscept
mous
strain
eae
cia
model
discoveri
inexplic
differ
attribut
proinflammatori
role
follow
reevalu
phenotyp
differ
mous
strain
discoveri
suggest
even
complex
mice
lack
mice
lack
observ
warrant
reassess
phenotyp
attribut
either
fact
could
featur
attribut
collison
vignali
despit
complic
studi
util
mous
strain
provid
substanti
evid
confirm
role
amelior
inflamm
variou
autoimmun
chronic
inflammatori
set
thu
mediat
suppress
effect
model
inflammatori
bowel
diseas
eae
collageninduc
arthriti
myocard
liver
fibrosi
name
collison
other
niedbala
other
kochetkova
other
tirotta
other
sever
recent
studi
complement
genet
delet
approach
gene
therapybas
tool
util
either
plasmid
dna
encod
singlechain
fusion
protein
intraperiton
inject
recombin
transgen
mice
ectop
express
approach
confer
protect
mous
model
allerg
airway
inflamm
coliti
diabet
huang
other
wirtz
other
bettini
other
recent
studi
expand
protect
effect
overexpress
murin
acut
graftversushost
diseas
viral
myocard
atherosclerosi
huang
other
hu
other
liu
other
involv
tumor
progress
tumor
immun
surveil
trace
back
earlier
observ
demonstr
increas
express
ebvassoci
hodgkin
lymphoma
diffus
larg
bcell
lymphoma
nasopharyng
carcinoma
acut
myeloid
leukemia
cell
niedobitek
other
subunit
associ
tumor
cell
provid
earli
implic
role
tumor
microenviron
niedobitek
other
larousseri
other
treg
inhibitori
cytokin
induc
regulatori
popul
highli
preval
peripher
blood
tumor
microenviron
mous
tumor
model
cancer
patient
liyanag
other
wolf
other
furthermor
recent
studi
suggest
role
tregderiv
limit
antitumor
immun
collison
other
regulatori
popul
cell
shown
contribut
significantli
regulatori
milieu
tumor
microenviron
therebi
confirm
critic
role
regulatori
triad
treg
cell
tumor
progress
collison
other
addit
treg
induc
regulatori
popul
tumorinfiltr
dendrit
cell
also
shown
express
although
product
tolerogen
dendrit
cell
remain
explor
niedobitek
other
larousseri
other
stabl
express
lung
cancer
cell
promot
tumor
progress
sirnamedi
gene
silenc
inhibit
cancer
cell
prolifer
nishino
other
fact
high
express
lung
cancer
cell
shown
associ
poor
prognosi
nishino
other
similarli
mice
protect
lung
metastasi
upon
intraven
inject
tumor
cell
line
mainli
associ
induct
ifngreleas
killer
dendrit
cell
ikdc
lung
augment
local
tcell
antitumor
respons
sauer
other
anoth
recent
report
demonstr
role
tumorderiv
promot
tumor
growth
accumul
suppress
myeloid
cell
popul
mdsc
increas
angiogenesi
wang
other
cancer
cell
line
consider
increas
tumorigenesi
immunecompet
immunedefici
mice
tumor
model
plasmacytoma
melanoma
treatment
antibodi
abrog
tumor
enhanc
confirm
specif
effect
tumor
show
signific
infiltr
mdsc
link
promot
tumor
angiogenesi
product
vascular
endotheli
growth
factor
proangiogenesi
factor
mdsc
also
mediat
immun
suppress
inhibit
cytotox
tcell
respons
line
tumor
reduc
cytotox
lymphocyt
ctl
respons
although
directli
affect
ctl
activ
effector
function
inde
deplet
mdsc
mab
abrog
tumor
progress
confirm
critic
role
mdsc
accumul
tumorigenesi
mediat
wang
other
produc
tumor
cell
also
shown
play
role
make
tumor
cell
resist
ctlmediat
destruct
upregul
express
tumor
cell
importantli
signal
associ
cancer
cell
resist
chemotherapi
overexpress
tumor
cell
also
induc
cell
cycl
arrest
phase
sensit
tumor
cell
infiltr
cell
serum
starvationinduc
apoptosi
long
other
thu
vari
mechan
may
actual
help
tumor
cell
evad
immun
surveil
establish
longterm
toler
therebi
promot
tumorigenesi
sinc
produc
tumor
cell
well
tumorinfiltr
treg
induc
regulatori
cell
possibl
popul
tumor
microenviron
better
understand
cross
talk
popul
would
allow
effect
target
regulatori
milieu
therapeut
purpos
consider
literatur
highlight
suppress
potenti
variou
mous
model
compar
valid
human
counterpart
limit
earlier
studi
fail
detect
product
human
treg
direct
ex
vivo
follow
cell
receptor
tcr
stimul
bardel
other
ectop
express
could
induc
express
human
cell
allan
other
differ
could
partial
explain
observ
data
mine
studi
suggest
constitut
express
human
tissu
unlik
tgfb
may
get
induc
certain
tissu
cell
type
respons
variou
inflammatori
stimuli
li
other
may
inde
true
sinc
shown
human
treg
face
strong
inflammatori
stimuli
eg
follow
rhinoviru
hepat
c
viru
infect
secret
suggest
induct
mayb
novel
activ
program
human
cell
respond
viral
infect
langhan
other
seyerl
other
human
cell
expos
also
express
mediat
suppress
effect
analog
mous
counterpart
collison
other
addit
human
regulatori
cell
popul
express
secret
shown
regul
antitumor
immun
respons
prostat
cancer
olson
other
interestingli
seem
increas
number
report
document
increas
decreas
level
human
sampl
varieti
diseas
state
tabl
although
warrant
rigor
assess
term
reagent
control
use
detect
overal
trend
suggest
increas
serum
level
correl
acut
myeloid
leukemia
increas
plasma
concentr
also
correl
newli
diagnos
acut
myeloid
leukemia
patient
one
common
hematolog
malign
adult
wu
other
reduc
circul
level
human
autoimmun
diseas
multipl
sclerosi
ms
serum
level
lower
ms
patient
treatment
interferon
b
methylprednisolon
combin
offer
benefici
effect
upregul
product
jafarzadeh
other
asthma
chronic
obstruct
pulmonari
diseas
copd
express
mrna
protein
downregul
asthmat
children
serum
level
invers
relat
serum
posit
correl
serum
ifng
level
chen
other
other
allerg
rhiniti
serum
express
also
significantli
reduc
allerg
rhiniti
patient
rel
normal
control
wan
other
ulcer
coliti
uc
crohn
diseas
cd
serum
level
also
significantli
reduc
ulcer
coliti
uc
crohn
diseas
cd
patient
suggest
insuffici
antiinflammatori
activ
vivo
differ
correl
studi
offer
consist
themeincreas
express
tumor
malign
decreas
express
autoimmun
chronic
inflammatori
condit
fig
observ
reconcil
highlight
critic
inform
inhibitori
cytokin
first
level
may
correl
degre
treg
infiltr
differ
diseas
thu
treg
induc
regulatori
popul
heavili
infiltr
induc
tumor
microenviron
imped
tumor
immun
surveil
autoimmun
chronic
inflamm
associ
reduc
treg
number
second
express
may
associ
maxim
treg
function
may
mark
highli
suppress
treg
explain
high
function
tumorassoci
treg
treg
autoimmun
inflammatori
environ
impair
suppressor
potenti
third
level
may
highli
indic
degre
treg
stabil
across
spectrum
immunolog
diseas
high
express
increas
treg
tumor
may
indic
highli
stabl
treg
impair
antitumor
immun
respons
hand
reduc
level
decreas
proport
treg
may
underli
basi
develop
autoimmun
chronic
inflamm
observ
encourag
rigor
assess
function
scope
human
requir
fulli
evalu
therapeut
potenti
blockad
cancer
administr
autoimmun
inflammatori
diseas
recent
studi
bcellderiv
expand
regulatori
scope
cellular
lineag
apart
treg
given
breg
field
focus
entir
sole
mechan
suppress
past
sever
year
discoveri
breg
cell
also
suppress
secret
mark
signific
progress
addit
given
recent
observ
express
induc
mani
human
tissu
condit
promot
inflamm
reason
predict
new
cellular
sourc
target
may
identifi
expand
rang
cell
tissu
suscept
immun
regul
importantli
breg
cell
induc
treg
tregderiv
also
sustain
breg
cell
thu
inflammatori
scenario
elicit
regulatori
milieu
differ
popul
may
promot
reciproc
activ
posit
feedforward
mechan
result
induct
cell
breg
infecti
toler
fig
may
particularli
relev
tumor
set
heavili
infiltr
treg
breg
suppress
popul
true
approach
boost
target
may
result
recruit
blockad
respect
b
cell
arm
immun
respons
offer
broader
therapeut
benefit
key
challeng
need
resolv
question
need
address
greater
understand
physiolog
import
therapeut
promis
establish
progress
field
rel
slow
due
signific
challeng
relat
uniqu
biolog
given
variou
receptor
share
compon
famili
cytokin
receptor
dissect
determin
true
contribut
challeng
major
hindranc
progress
field
lack
critic
reagent
lack
mutant
mous
model
condit
tempor
delet
receptor
chain
major
limit
would
also
highli
desir
report
cre
line
assess
express
fate
cell
express
anoth
major
limit
lack
purifi
recombin
mous
human
question
activ
puriti
recombin
version
avail
last
lack
avail
good
antibodi
particular
receptor
also
signific
limit
avail
qualiti
key
reagent
dictat
pace
futur
progress
import
determin
physiolog
relev
contribut
vivo
known
cellular
sourc
especi
treg
cell
breg
also
import
determin
cellular
sourc
physiolog
signific
given
appar
complex
receptor
util
studi
need
clearli
establish
whether
combin
physiolog
relev
requir
also
need
gain
greater
understand
distribut
receptor
cell
impact
intracellular
mechan
action
remain
larg
unknown
inhibit
cell
cycl
progress
receptor
induc
andor
differ
cell
type
mediat
suppress
induct
stat
mediat
proinflammatori
event
activ
differ
cytokin
receptor
addit
receptor
signal
mechan
realli
differ
versu
b
cell
simpli
put
need
know
work
import
human
also
need
fulli
rigor
establish
also
need
determin
mechan
action
human
cell
mous
cell
sever
clinic
relev
question
remain
viabl
therapeut
target
cancer
could
recombin
use
treat
autoimmun
inflammatori
diseas
last
need
rigor
assess
express
differ
tissu
cell
type
diseas
set
determin
util
diagnost
biomark
overal
expand
job
profil
gener
enthusiasm
also
rais
signific
question
challeng
need
resolv
expans
sourc
target
new
role
ascrib
beyond
inhibit
prolifer
infecti
toler
name
modul
tcell
differenti
program
expans
treg
regul
apc
function
b
cell
thu
far
nevertheless
remain
inhibitori
cytokin
seem
oppos
pleiotrop
activ
mani
cytokin
indepth
studi
warrant
use
recombin
special
mous
model
propos
appropri
cellular
lineag
fulli
appreci
physiolog
impact
understand
cross
talk
variou
cell
popul
treg
breg
treg
divers
diseas
set
overal
regulatori
network
establish
uniqu
suppress
cytokin
greatli
aid
effect
manipul
translat
benefit
